Showing 1 - 3 results of 3 for search 'Rordorf C', query time: 0.02s Refine Results
  1. 1
    The phagocyte specific protein S100A12 as a novel biomarker in Muckle-Wells-Syndrome before and during therapy with Anakinra and Canakinumab (ACZ885)

    The phagocyte specific protein S100A12 as a novel biomarker in Muckle-Wells-Syndrome before and during therapy with Anakinra and Canakinumab (ACZ885) by Wittkowski H, Kuemmerle-Deschner JB, Gramlich K, Tzaribachev N, Felix SD, Jung T, Roth J, Rordorf C, Foell D

    Published 2008
    Connect to this object online.
    Book
    Save to List
    Saved in:
  2. 2
    12.4 ACZ885 (canakinumab), a new IL-1 beta blocking monoclonal antibody provides long-lasting remission in children with cryopyrin associated periodic syndrome (CAPS)

    12.4 ACZ885 (canakinumab), a new IL-1 beta blocking monoclonal antibody provides long-lasting remission in children with cryopyrin associated periodic syndrome (CAPS) by Kümmerle-Deschner J, Blank N, Roesler J, Ramos E, Tzaribachev N, Gramlich K, Well C, Felix SD, Rordorf C, Jung T

    Published 2008
    Connect to this object online.
    Book
    Save to List
    Saved in:
  3. 3
    2.2 A phase II trial with canakinumab, a new IL-1beta blocking monoclonal antibody (ACZ885), to evaluate preliminary dosing, safety and efficacy profile in children with systemic Juvenile Idiopathic arthritis (sJIA)

    2.2 A phase II trial with canakinumab, a new IL-1beta blocking monoclonal antibody (ACZ885), to evaluate preliminary dosing, safety and efficacy profile in children with systemic J... by Ruperto N, Quartier P, Wulffraat N, Woo P, Loy A, Mouy R, Bader-Meunier B, Prakken B, Noseda E, Rordorf C

    Published 2008
    Connect to this object online.
    Book
    Save to List
    Saved in:

Search Tools: